← Open Payments lookup

MITSI LONG: Open Payments

NPI 1740801752 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$784 in 38 payments from 8 companies in 2025. Trend: 2023 $1,695 · 2024 $1,199 · 2025 $784

Food & beverage: $694Education: $90
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.17$399
Teva Pharmaceuticals USA, Inc.10$205
Janssen Pharmaceuticals, Inc5$89
Alkermes, Inc.2$31
E.R. Squibb & Sons, L.L.C.1$19
ABBVIE INC.1$14
Otsuka America Pharmaceutical, Inc.1$14
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$14

Products named: INGREZZA, AUSTEDO XR, INVEGA SUSTENNA, ARISTADA, COBENFY, UZEDY, VRAYLAR, ABILIFY ASIMTUFII.

Industry payments across LA — which companies pay providers there.